Akoya Biosciences Inc
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImag… Read more
Akoya Biosciences Inc (AKYA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 1.225x
Based on the latest financial reports, Akoya Biosciences Inc (AKYA) has a cash flow conversion efficiency ratio of 1.225x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.21 Million) by net assets ($-5.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Akoya Biosciences Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Akoya Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Akoya Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Akoya Biosciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kaya Limited
NSE:KAYA
|
-0.131x |
|
Greenway Technologies Inc
PINK:GWTI
|
0.022x |
|
Caspin Resources Ltd
AU:CPN
|
-0.288x |
|
Kisan Telecom Co. Ltd
KQ:035460
|
-0.029x |
|
Eminent Luggage Corporation
TWO:9950
|
0.009x |
|
Dongbang Agro
KO:007590
|
0.011x |
|
HCL Infosystems Limited
NSE:HCL-INSYS
|
-0.001x |
|
Llorente & Cuenca S.A.
MC:LLYC
|
0.283x |
Annual Cash Flow Conversion Efficiency for Akoya Biosciences Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Akoya Biosciences Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $7.59 Million | $-44.10 Million | -5.807x | -513.44% |
| 2023-12-31 | $53.77 Million | $-50.90 Million | -0.947x | -3.66% |
| 2022-12-31 | $58.58 Million | $-53.50 Million | -0.913x | -207.25% |
| 2021-12-31 | $121.35 Million | $-36.07 Million | -0.297x | +19.34% |
| 2020-12-31 | $18.57 Million | $-6.84 Million | -0.368x | -180.67% |
| 2019-12-31 | $-30.16 Million | $-13.78 Million | 0.457x | -- |